We could not find any results for:
Make sure your spelling is correct or try broadening your search.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T cell therapies to treat cancer and other life-threatening illnesses. MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T cell therapies to treat cancer and other life-threatening illnesses.
MiNK-215 eliminated MSS colorectal cancer liver metastases in human organoid modelsMiNK-215 exhibits potent anti-tumor activity through multiple mechanisms including immune activation NEW YORK...
U.S. index futures are showing an uptrend in Thursday’s pre-market, driven by the record close of the three major indexes in the previous session and the more “dovish” stance...
Launched and enrolling Phase 2 trial of allo-iNKTs with botensilimab/balstilimab and chemotherapy in second-line gastroesophageal cancers Announced collaboration with Immunoscape for development...
NEW YORK, March 07, 2024 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of...
Dr. Yelena Janjigian, Chief of GI Cancers, Leads Investigator Sponsored Study at Memorial Sloan Kettering Cancer CenterTrial is Supported by Stand Up To Cancer as Part of an Initiative to Find...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0093 | 1.01274093434 | 0.9183 | 0.96 | 0.86 | 50502 | 0.87828883 | CS |
4 | 0.0086 | 0.935799782372 | 0.919 | 1.9 | 0.86 | 203961 | 1.31252028 | CS |
12 | 0.0376 | 4.22471910112 | 0.89 | 1.9 | 0.78 | 102159 | 1.17474479 | CS |
26 | 0.0076 | 0.826086956522 | 0.92 | 1.9 | 0.75 | 72048 | 1.11013332 | CS |
52 | -1.1424 | -55.1884057971 | 2.07 | 3.34 | 0.75 | 98833 | 1.49381939 | CS |
156 | -11.1124 | -92.2956810631 | 12.04 | 22.155 | 0.75 | 113163 | 3.07512597 | CS |
260 | -11.1124 | -92.2956810631 | 12.04 | 22.155 | 0.75 | 113163 | 3.07512597 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions